AMIVAS, LLC

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	4	1
2022	—	6	1
2021	—	5	1
2020	—	7	1
2019	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BUCHANAN INGERSOLL & ROONEY PC	—	26

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Food & Drug Administration (FDA)	15
HOUSE OF REPRESENTATIVES	15
SENATE	15

Most frequently reported lobbying issues

Issue Code	Description	Reports
Homeland Security	Homeland Security	16
Veterans	Veterans	16
Health Issues	Health Issues	16
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	16

AMIVAS, LLC — Lobbying Disclosure | Poliscope